Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®

Allergan

Status: Completed

Conditions: Glabellar Lines

Treatments: Biological: botulinum toxin Type A

Study type: Observational

Funder types: Industry

Identifiers

NCT01608672

GMA-BTXC-11-004

Details and patient eligibility

About

This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.

Enrollment: 207 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least one BOTOX® treatment for facial wrinkles (glabellar lines) per calendar year for ≥5 years

Exclusion criteria

• Received botulinum toxin formulations other than BOTOX®

Trial design

207 participants in 1 patient group

All participants

Description:

Botulinum toxin Type A (BOTOX®) treatment to glabellar lines as prescribed by the Investigator over at least 5 years.

Treatment:

Biological: botulinum toxin Type A